The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The expression of neural cell adhesion molecule and the microenvironment of pituitary neuroendocrine tumours
Authors
Keywords
-
Journal
JOURNAL OF NEUROENDOCRINOLOGY
Volume 33, Issue 12, Pages -
Publisher
Wiley
Online
2021-10-09
DOI
10.1111/jne.13052
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cell adhesion in cancer: Beyond the migration of single cells
- (2020) Michalina Janiszewska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
- (2020) Jacqueline Trouillas et al. Cancers
- TGF-β1 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation
- (2020) Donatella Delle Cave et al. ONCOGENE
- Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer
- (2019) Sunil Singhal et al. Science Translational Medicine
- Prognostic significance of CD68+ and CD163+ tumor associated macrophages in head and neck squamous cell carcinoma: A systematic review and meta-analysis
- (2019) Giuseppe Troiano et al. ORAL ONCOLOGY
- Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
- (2019) Heidi Harjunpää et al. Frontiers in Immunology
- Chemokines modulate the tumour microenvironment in pituitary neuroendocrine tumours
- (2019) Pedro Marques et al. Acta Neuropathologica Communications
- Pituitary tumour fibroblast-derived cytokines influence tumour aggressiveness
- (2019) Pedro Marques et al. ENDOCRINE-RELATED CANCER
- Definition and diagnosis of aggressive pituitary tumors
- (2019) Leandro Kasuki et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
- Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer
- (2018) Young Kwang Chae et al. Scientific Reports
- Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
- (2018) Emily Rodrigues et al. Cancers
- Gene and protein expression of E-cadherin and NCAM markers in non-functioning pituitary adenomas
- (2018) Bárbara Roberta Ongaratti et al. Annals of Diagnostic Pathology
- Trophic and neurotrophic factors in human pituitary adenomas (Review)
- (2017) Marialuisa Spoletini et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Diagnosis and Treatment of Pituitary Adenomas
- (2017) Mark E. Molitch JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Risk of Recurrence in Pituitary Neuroendocrine Tumors: A Prospective Study Using a Five-Tiered Classification
- (2017) Gérald Raverot et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- CD56 in the Immune System: More Than a Marker for Cytotoxicity?
- (2017) Heleen H. Van Acker et al. Frontiers in Immunology
- NCAM- and FGF-2-mediated FGFR1 signaling in the tumor microenvironment of esophageal cancer regulates the survival and migration of tumor-associated macrophages and cancer cells
- (2016) Nobuhisa Takase et al. CANCER LETTERS
- Increased expression of programmed death ligand 1 (PD-L1) in human pituitary tumors
- (2016) Yu Mei et al. Oncotarget
- Molecular and clinical significance of fibroblast growth factor 2 (FGF2 /bFGF) in malignancies of solid and hematological cancers for personalized therapies
- (2016) Mohamed R. Akl et al. Oncotarget
- Pituitary Tumors
- (2015) Shlomo Melmed ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up
- (2013) Jacqueline Trouillas et al. ACTA NEUROPATHOLOGICA
- Fibroblast Growth Factor-2 Signaling in Neurogenesis and Neurodegeneration
- (2013) Maya E. Woodbury et al. Journal of Neuroimmune Pharmacology
- Transforming growth factor-beta1 induces microvascular abnormalities through a down-modulation of neural cell adhesion molecule in human hepatocellular carcinoma
- (2012) Piera Balzarini et al. LABORATORY INVESTIGATION
- The adhesion molecule NCAM promotes ovarian cancer progression via FGFR signalling
- (2011) Silvia Zecchini et al. EMBO Molecular Medicine
- Adhesion molecules
- (2011) Guangwen Ren et al. Cell Adhesion & Migration
- The CXCR4 antagonist AMD3100 suppresses hypoxia-mediated growth hormone production in GH3 rat pituitary adenoma cells
- (2010) D. Yoshida et al. JOURNAL OF NEURO-ONCOLOGY
- L1 cell adhesion molecule (L1CAM) in invasive tumors
- (2009) Shani Raveh et al. CANCER LETTERS
- Tumor Infiltrating Lymphocytes But Not Serum Pituitary Antibodies Are Associated with Poor Clinical Outcome after Surgery in Patients with Pituitary Adenoma
- (2009) Isabella Lupi et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Overexpression of Stromal Cell-Derived Factor 1 and Its Receptor CXCR4 Induces Autocrine/Paracrine Cell Proliferation in Human Pituitary Adenomas
- (2008) F. Barbieri et al. CLINICAL CANCER RESEARCH
- A novel anti-inflammatory role of NCAM-derived mimetic peptide, FGL
- (2008) Eric J. Downer et al. NEUROBIOLOGY OF AGING
- NCAM-induced intracellular signaling revisited
- (2007) Dorte Kornerup Ditlevsen et al. JOURNAL OF NEUROSCIENCE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search